The US Food and Drug Administration (FDA) has issued a warning letter to NeoChild for alleged misbranding of its neonatal devices and procedural errors.
The US Food and Drug Administration (FDA) has issued a warning letter to NeoChild for alleged misbranding of its neonatal devices and procedural errors.
The FDA stated that the firm marketed its SafeChild System's enteral feeding tubes and extension sets before filing a premarket approval or getting 510(k) clearance. In addition, the July 29 letter stated that the silicone and polyurethane enteral feeding tubes and the PVC extension sets were not approved for an investigational device exemption.
NeoChild is to submit a premarket approval so the FDA can evaluate the information and decide whether the products may be marketed legally.
In addition, the FDA also cited NeoChild for failure to develop or implement written medical device report procedures from the time it started distributing devices in March 2007 to the date of an April inspection.
Stress ulcer prophylaxis does not provide prevention of gastrointestinal bleeding in neonates
December 4th 2023In a poster abstract presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, stress ulcer prophylaxis (SUP) did not appear to provide benefit for prevention of gastrointestinal bleeding and did not increase SUP-associated adverse effects.
Hematocrit levels in newborns: EPP vs DCC study reveals surprising findings
November 15th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
Preterm infant HRQOL: Long-term impacts and determinants
October 21st 2023A recent study was highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition that shed light on the long-term impact of very preterm birth on the health-related quality of life (HRQOL) of infants and identified key determinants.
Associations between prenatal metal mixture exposure and negative infant outcomes
September 19th 2023Francheska M. Merced-Nieves, PhD, Assistant professor, Departments of Pediatrics and the Institute for Exposomic Research of Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, explains the associations prenatal exposure to a metal mixture and the potential negative effects for the infant.